On the heels of Cumberland Pharmaceuticals’ founding, BioMimetic Therapeutics Inc. relocates from New York to Nashville. This geographical move is important because BioMimetic will go on to be one of the city’s largest life sciences companies and create an incubator for the sector in Nashville.

BioMimetic will complete an IPO in 2010 and exceed even its own expectations by raising $45 million in net proceeds.